What is Nowatch?
NOWATCH is a health technology company focused on providing innovative tools for navigating the digital health landscape. Founded by Hylke Muntinga and Timothée Manschot, the brand's flagship product, the NOWATCH, is a pioneering wearable device designed to measure and predict stress by tracking cortisol levels. This technology aims to help users preempt burnout by alerting them to potential stress triggers up to 60 minutes in advance. The NOWATCH features a screenless, customizable gemstone face and monitors various health metrics, including temperature, heart rate, movement, and sleep, all with the objective of restoring balance for comprehensive mind and body wellbeing.
How much funding has Nowatch raised?
Nowatch has raised a total of $8.7M across 1 funding round:
Series A
$8.7M
Series A (2022): $8.7M with participation from Flow Ventures and Chris Hall
Key Investors in Nowatch
Flow Ventures
Flow Ventures is identified as a SR&ED consulting firm with extensive experience in helping companies maximize their SR&ED refunds, suggesting a focus on innovation and technology development.
Chris Hall
Chris Hall is an individual investor who participated in this funding round, indicating personal belief in Nowatch's mission and technology.
What's next for Nowatch?
With its recent Series A financing, Nowatch is poised for significant scaling and further development of its predictive stress-monitoring technology. The substantial enterprise-level funding will likely fuel expansion into new markets, enhance product research and development, and bolster marketing efforts to reach a wider audience seeking proactive wellness solutions. This strategic capital infusion positions Nowatch to solidify its leadership in the wearable health tech industry.
See full Nowatch company page
